MiNK Therapeutics Inc.

INKT | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.03

-$0.22 (-1.80%)

Sep 22, 2026, 11:36 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $61.03M

Enterprise Value $-8.75B

Beta 0.49

Average Volume 24.07K

Shares Outstanding (Diluted) 5.02M

Shares Change YoY 26.15%

Institutional Ownership 2.64%

Exchange NASDAQ

ISIN US6036932019

Price Performance

Price Change 1M 3.4%

Price Change 3M -0.7%

Price Change 6M 34.2%

Price Change YTD 10.2%

Price Change 1Y -24.9%

Price Change 3Y -5.8%

Price Change 5Y -89.8%

1M CAGR (ann.) 11.9%

1Y CAGR (ann.) -20.2%

5Y CAGR (ann.) N/A

All-Time CAGR -37.0%

Valuation

PE Ratio -5.13

Forward PE N/A

PEG Ratio -0.30

Forward PEG -0.77

PS Ratio N/A

Forward PS 15.30

PB Ratio 0.01

P/FCF Ratio -0.03

P/Adj. FCF Ratio -0.01

P/OCF Ratio -0.03

EV/Sales N/A

EV/EBIT 1,063.31

EV/EBITDA 1,078.82

EV/FCF 4.19

Earnings Yield -19.5%

FCF Yield -3420.6%

Adj. FCF Yield -8492.6%

Financial Health

Net Cash $8.81B

Total Debt $0

Cash & Short-Term Investments $8.81B

Total Assets $9.62B

Current Ratio 1.23

Quick Ratio 1.23

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -23.67

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -148.3%

Returns

Return on Assets -118.2%

Return on Equity 83.5%

Return on Invested Capital -604.2%

Return on Capital Employed -604.2%

Return on Tangible Assets -118.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 37.0%

EPS CAGR 5Y 35.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y -90.3%

FCF CAGR 5Y -78.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 10.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.35

EPS Growth Est (next Q) -46.1%

Revenue Est (next Q) $1.6M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $35

Price Target Upside 185.7%

Cash Flow

Operating Cash Flow $-2.09B

Free Cash Flow $-2.09B

Adj. Free Cash Flow $-5.18B

FCF Per Share -$415.56

OCF Per Share -$415.56

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-118.28K

Operating Income $-9.15M

EBITDA $-8.11M

Net Income $-3.14B

EPS (Diluted) -$2.39

Revenue / Employee N/A

Profit / Employee $-209.1M

Employees 15